戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n of both TI-2 memory B cells and long-lived antibody secreting cells.
2 , indicating local maintenance of protective antibody secreting cells.
3 icroneutralisation titres, and the number of antibody secreting cells.
4 le to screening both bacterial and mammalian antibody secreting cells.
5  systemic antigen-specific IgG(+) and IgA(+) antibody secreting cells.
6 stigation of differentiation of B cells into antibody secreting cells.
7 tiation of Foxp3+ regulatory T cells and IgA antibody-secreting cells.
8 ional and morphological differentiation into antibody-secreting cells.
9 d native antigens and differentiate into VLR antibody-secreting cells.
10 tion of the preexisting and newly-developing antibody-secreting cells.
11 on, class switching and differentiation into antibody-secreting cells.
12 ant increases in the numbers of specific IgA antibody-secreting cells.
13 lection and maturation into broadly-reacting antibody-secreting cells.
14 um responses and developed S. typhi-specific antibody-secreting cells.
15 ntibody to hepatitis pre-S or pre-S-specific antibody-secreting cells.
16 rotavirus, as determined by assay of mucosal antibody-secreting cells.
17 sion and the differentiation of B cells into antibody-secreting cells.
18 ndrial homeostasis and alterations in GC and antibody-secreting cells.
19 lergen tolerance through apoptosis of IgE(+) antibody-secreting cells.
20 production, and failed to differentiate into antibody-secreting cells.
21  decreased the expression of Xbp1 in Blimp1+ antibody-secreting cells.
22 ero-mammary link may exist for food-specific antibody-secreting cells.
23 ation of human B cells into memory cells and antibody-secreting cells.
24  and preserved ability to differentiate into antibody-secreting cells.
25 B-cells, cycling/germinal center B-cells and antibody-secreting cells.
26 IgG class switching, and differentiated into antibody-secreting cells.
27 ing, and increased the numbers of anti-HIV-1 antibody-secreting cells.
28 emory B cells and no evidence of circulating antibody-secreting cells.
29  T-dependent B cell memory and high affinity antibody-secreting cells.
30  rapid conversion of naive B cells to mature antibody-secreting cells.
31 ntibodies (blood and stool) and RBD-specific antibody-secreting cells.
32  the TIV group and correlated with number of antibody-secreting cells.
33 nd facilitates differentiation of long-lived antibody-secreting cells.
34  The increase in frequency of donor-specific antibody-secreting cells after renal transplantation ind
35 ncies of memory B cells and antigen-specific antibody-secreting cells after vaccination.
36 ease in antibody titer, reduced frequency of antibody secreting cells, an absence of affinity maturat
37 a, and this colonization induced significant antibody-secreting cell and enzyme-linked immunosorbent
38 ish 10 mo postchallenge led to activation of antibody-secreting cells and a more rapid production of
39 cific B and T cells after i.n. immunization, antibody-secreting cells and antigen-responsive T cells
40 nduced high levels of S-specific IgG and IgA antibody-secreting cells and antigen-specific CD4(+) T c
41 also led to increased levels of HIV-specific antibody-secreting cells and B cell-associated chemokine
42  this article, we will review the biology of antibody-secreting cells and focus on therapeutics that
43                                  NP-specific antibody-secreting cells and heightened frequencies of g
44 carrier protein, leading to large numbers of antibody-secreting cells and high titers of high-affinit
45 follicular helper cells correlates with peak antibody-secreting cells and influenza heamaglutinin-spe
46 Moreover, significantly lower numbers of IgG antibody-secreting cells and lower levels of CD4(+)-T-ce
47 irus strain correlate with low production of antibody-secreting cells and memory B cells recognizing
48                                              Antibody-secreting cells and memory B cells specific for
49 uction of higher levels of envelope-specific antibody-secreting cells and memory B cells, higher IgG
50 veals the capacity of memBcs to develop into antibody-secreting cells and present an idea for a new c
51  inhibitor to murine BMI-1, we could deplete antibody-secreting cells and prohibit detrimental immune
52  RSV-specific, T-cell-dependent neutralizing antibody-secreting cells and RSV-specific memory respons
53 sma cell subsets, such as early-minted blood antibody-secreting cells and the bone marrow LLPC, and h
54 es to SARS-CoV-2, including the frequency of antibody-secreting cells and the presence of SARS-CoV-2-
55  (NV-specific IgA and immunoglobulin G [IgG] antibody-secreting cells and total and NV-specific IgA a
56 y lower levels of germinal center formation, antibody-secreting cells, and circulating influenza viru
57 l center (GC) reaction, increased anti-gp120 antibody-secreting cells, and increased anti-gp120 funct
58 ve rise to class-switched memory B cells and antibody-secreting cells, and likely contribute signific
59 indings show that memory B cells and natural antibody-secreting cells are BLyS-independent and sugges
60                                        These antibody-secreting cells are part of a larger subset of
61                                We identified antibody-secreting cells as the major splenic B cell pop
62 specifically the impact on the maturation of antibody-secreting cells, as a potential mechanism under
63                             Because gut IgA+ antibody secreting cells (ASC) are poorly defined a flow
64 owing infection or vaccination, early-minted antibody secreting cells (ASC) or plasmablasts appear in
65  Immunoglobulin in cerebral spinal fluid and antibody secreting cells (ASC) within the central nervou
66 gamma producing cells (IFN-gamma PC) and IgA antibody secreting cells (ASC).
67                                              Antibody-secreting cell (ASC) and memory B-cell (MBC) re
68       The transcriptional network regulating antibody-secreting cell (ASC) differentiation has been e
69 ly elevated circulating immunoglobulin (Ig)G antibody-secreting cell (ASC) frequencies and hypergamma
70 vestigated the kinetics of the FMDV-specific antibody-secreting cell (ASC) response following homolog
71             A dose-related, immunoglobulin A antibody-secreting cell (ASC) response to S. flexneri 2a
72 ve increases in humoral and antigen-specific antibody-secreting cell (ASC) responses after each dose
73  measure local and systemic isotype-specific antibody-secreting cell (ASC) responses to individual st
74  interferon-gamma (IFN-gamma) and long-lived antibody-secreting cell (ASC) responses, the roles for I
75 IgG responses, and all but one volunteer had antibody-secreting cell (ASC) responses.
76                             Isotype-specific antibody-secreting cells (ASC were enumerated at selecte
77                    In vivo antigen-activated antibody-secreting cells (ASC) (effector B cells) and in
78 on-isotype-switched, memory (Bmem) cells and antibody-secreting cells (ASC) accumulate in various mod
79 id differentiation to become HA-specific IgG antibody-secreting cells (ASC) after activation in non-T
80 aluated immunoglobulin M (IgM), IgA, and IgG antibody-secreting cells (ASC) and cytokine-secreting ce
81 eir antibody affinity and differentiate into antibody-secreting cells (ASC) and memory cells.
82                                              Antibody-secreting cells (ASC) and serum antibody titers
83 r immunoglobulin A (IgA) and IgG circulating antibody-secreting cells (ASC) and stimulated memory B c
84                                              Antibody-secreting cells (ASC) are the effectors of prot
85 responses were determined from the number of antibody-secreting cells (ASC) in blood measured by enzy
86 ified by the frequency of influenza-specific antibody-secreting cells (ASC) in peripheral blood, was
87 ibody titers, and significant numbers of IgG antibody-secreting cells (ASC) in the spleen and tracheo
88  induced activation and differentiation into antibody-secreting cells (ASC) of CBC but not IBC when t
89 F-specific antibodies and fewer 23F-specific antibody-secreting cells (ASC) than did BALB/c or (CBA/J
90 hat were associated with the localization of antibody-secreting cells (ASC) to the bone marrow.
91 cle-treated mice, virus-specific IgM and IgG antibody-secreting cells (ASC) were decreased 22- and 45
92          To assess correlates of protection, antibody-secreting cells (ASC) were enumerated in intest
93                       The highest numbers of antibody-secreting cells (ASC), both IgA and IgG, were d
94 potent and selective chemoattractant for IgA antibody-secreting cells (ASC), efficiently recruiting I
95                                FMDV-specific antibody-secreting cells (ASC), predominantly IgM, were
96 rast, in STV there was a lack of circulating antibody-secreting cells (ASC), reflecting the local muc
97 tactivated B-cell subsets, including MBC and antibody-secreting cells (ASC), with maximal expression
98 s, with only a fraction differentiating into antibody-secreting cells (ASC).
99 rders are often associated with retention of antibody-secreting cells (ASC).
100  nature and homing potentials of circulating antibody-secreting cells (ASC).
101   Active SLE generates increased circulating antibody-secreting cells (ASC).
102 IgM(-) memory B cells (B(mem)), and CD138(+) antibody-secreting cells (ASC).
103       We analyzed the humoral responses (HI, antibody-secreting cell [ASC], and serum immunoglobulin
104 ibody responses (measured by quantitation of antibody-secreting cells [ASC] in intestinal and systemi
105 he mean numbers of HSV glycoprotein-specific antibody secreting cells (ASCs) and IFN-gamma SCs were g
106                                              Antibody secreting cells (ASCs) are critical effector ce
107 anut IgE levels, symptoms, or numbers of IgE antibody secreting cells (ASCs) in the BM.
108                                 HPV-specific antibody secreting cells (ASCs) were present in the tumo
109 ples were collected for serological profile, antibody secreting cells (ASCs), and analysis of ASC hom
110  influenza infection, the clonal dynamics of antibody secreting cells (ASCs), particularly those with
111 entification and recovery of target specific antibody secreting cells (ASCs).
112 pecificity and duration of circulating human antibody-secreting cells (ASCs) after vaccination have b
113 oglobulin A (IgA) and immunoglobulin G (IgG) antibody-secreting cells (ASCs) and influenza virus-spec
114      Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs
115                                              Antibody-secreting cells (ASCs) and memory B cells (MemB
116 ted a robust expansion of the virus-specific antibody-secreting cells (ASCs) and memory B cells in th
117                                              Antibody-secreting cells (ASCs) are considered work hors
118                                              Antibody-secreting cells (ASCs) are isolated from whole
119              We demonstrate that B cells and antibody-secreting cells (ASCs) are present in inflammat
120                                              Antibody-secreting cells (ASCs) are present in the CNS a
121 rbent assay (ELISA), and total IgG and dsDNA antibody-secreting cells (ASCs) by enzyme-linked immunos
122 ined that the measurement of Mp-specific IgM antibody-secreting cells (ASCs) by enzyme-linked immunos
123  measurement of Mp-specific immunoglobulin M antibody-secreting cells (ASCs) by enzyme-linked immunos
124 was to test the contribution of allospecific antibody-secreting cells (ASCs) from different anatomica
125 on in secondary lymphoid organs, a subset of antibody-secreting cells (ASCs) homes to the bone marrow
126 neumoniae (Mp)-specific immunoglobulin (Ig)M antibody-secreting cells (ASCs) improved diagnosis of Mp
127 pecific immunoglobulin A (IgA), IgG, and IgM antibody-secreting cells (ASCs) in a dose-responsive man
128 ons through the generation of class-switched antibody-secreting cells (ASCs) in germinal centers.
129  influenza-, tetanus- or SARS-CoV-2-specific antibody-secreting cells (ASCs) in long-lived plasma cel
130                         Germinal centers and antibody-secreting cells (ASCs) in spleens and IgG depos
131 s-specific antibodies and rotavirus-specific antibody-secreting cells (ASCs) in the circulation to pr
132 otype, magnitude, and tissue distribution of antibody-secreting cells (ASCs) in the intestinal and sy
133     The accumulation of immunoglobulin (Ig)A antibody-secreting cells (ASCs) in the lactating mammary
134  Bmem cells differentiated more rapidly into antibody-secreting cells (ASCs) in vitro.
135 The terminal differentiation of B cells into antibody-secreting cells (ASCs) is a critical component
136 erentiation of naive and memory B cells into antibody-secreting cells (ASCs) is a key feature of adap
137              Differentiation of B cells into antibody-secreting cells (ASCs) is a key process to gene
138                  B cell differentiation into antibody-secreting cells (ASCs) is a tightly regulated p
139 cell transition to memory B cells (MBCs) and antibody-secreting cells (ASCs) is crucial for clinical
140                                              Antibody-secreting cells (ASCs) or plasma cells secrete
141 ive-derived, low-mutation IgG1 population of antibody-secreting cells (ASCs) reflecting features of l
142                               HBsAg-specific antibody-secreting cells (ASCs) response was not differe
143        Here, we examined the lifespan of IgE antibody-secreting cells (ASCs) to determine whether the
144 dance of molecules involved in the homing of antibody-secreting cells (ASCs) to the bone marrow (BM).
145 n-reactivities were more concentrated within antibody-secreting cells (ASCs) versus B cells (P < 0.00
146 0, 1, and 3 months, and serum antibodies and antibody-secreting cells (ASCs) were assessed.
147            Frequencies of influenza-specific antibody-secreting cells (ASCs) were measured by enzyme-
148 ced memory T cell responses or PnPS-specific antibody-secreting cells (ASCs) were responsible for ser
149 s erythematosus (SLE) courses with surges of antibody-secreting cells (ASCs) whose origin, diversity
150 vaccination for the number of Spike-specific antibody-secreting cells (ASCs) with a mucosal tropism.
151  hemagglutination inhibition (HAI) activity, antibody-secreting cells (ASCs), and HA-specific compart
152 ) and immunoglobulin G (IgG), fecal IgA, IgA antibody-secreting cells (ASCs), and IFN-gamma productio
153 evated nasal IL-5 levels and high numbers of antibody-secreting cells (ASCs), including plasma cells
154 ls and their subsequent differentiation into antibody-secreting cells (ASCs).
155 d and tested by ELISpot for antigen-specific antibody-secreting cells (ASCs).
156 he differentiation of naive B cells (nBs) to antibody-secreting cells (ASCs).
157 h inter-individual convergence in memory and antibody-secreting cells (ASCs).
158 out IL-6 as a differentiation factor for IgM antibody-secreting cells (ASCs).
159 ng immunoglobulin G (IgG) antibodies and IgG antibody-secreting cells (ASCs).
160 ulting from significantly reduced numbers of antibody-secreting cells (ASCs).
161 he CNS were primarily CD8(+) T cells and IgM antibody-secreting cells (ASCs).
162                                              Antibody-secreting cells (ASCs; plasma cells and plasmab
163 differentiation of autoreactive B cells into antibody-secreting cells, but it is not necessary for th
164 y enzyme-linked immunosorbent assay and lung antibody secreting cells by enzyme-linked immunospot ass
165 ed using Luminex assays and the frequency of antibody-secreting cells by ELISpot.
166  relied on conversion of memory B cells into antibody-secreting cells by in vitro culture.
167 tavirus-specific, immunoglobulin A-producing antibody-secreting cell concentration in antibiotic-trea
168 9, 39, 278, and 233 for immunoglobulin (IgA) antibody-secreting cell counts; 401, 201, 533, and 284 f
169 mbers of bone marrow plasma cells and spleen antibody-secreting cells detected in the MN group.
170 that CD11c(+)Tbet(+) B cells were primed for antibody-secreting cell differentiation compared to rele
171               Functional characterization of antibody-secreting cell differentiation dynamics reveale
172                            T. cruzi-specific antibody-secreting cells disappeared from the circulatio
173                                        Thus, antibody-secreting cells do not exclusively control the
174 munity as they differentiate into protective antibody-secreting cells during re-infection.
175 increases in the frequency of donor-specific antibody-secreting cells eight weeks after transplantati
176 charide (LPS)-specific immunoglobulin (Ig) A antibody-secreting cells (enzyme-linked immunospot [ELIS
177 logy for cellular infiltration, and measured antibody-secreting cells (enzyme-linked immunospot assay
178 ar activation correlated strongly with large antibody-secreting cell expansion and early production o
179 g but sustained production of virus-specific antibody-secreting cells for months.
180 moniae infection exaggerates early antiviral antibody-secreting cell formation, and at later times, l
181 sponding decrease in secondary high-affinity antibody-secreting cell formation.
182  differentiation, and spleen and bone marrow antibody-secreting cell frequencies were 10-fold higher
183 molecular to the clinical level, we isolated antibody-secreting cells from the cerebrospinal fluid of
184  were characterized and compared to those of antibody-secreting cells from untreated ITP spleens and
185 o evaluate the diversity of antigen-specific antibody-secreting cells generated during an in vivo hum
186                                              Antibody-secreting cells had increased I34 levels and we
187 nt stimulus resulted in normal generation of antibody-secreting cells, however the patient's T cells
188                                Proliferative antibody-secreting cells, however, deviate from these gl
189 virus from the lung and enhanced humoral and antibody-secreting cell immune responses after 100% surv
190 imulated immunoglobulin A-producing anti-LPS antibody-secreting cells in 60, 91, and 100% of subjects
191 tence of Vi-specific IgG in serum and IgG(+) antibody-secreting cells in bone marrow.
192 uce protective CD8(+) T cells and long-lived antibody-secreting cells in CD4KO mice.
193 es of B cells, and numbers of virus-specific antibody-secreting cells in circulation of children hosp
194 ibody responses and in higher frequencies of antibody-secreting cells in corresponding draining cervi
195 selection and differentiation into activated antibody-secreting cells in mammalian germinal centers (
196 ), and the numbers of Campylobacter-specific antibody-secreting cells in peripheral blood failed to i
197  we revealed the infiltration of T cells and antibody-secreting cells in periventricular brain region
198  CCR9 can be expressed on IgM as well as IgA antibody-secreting cells in response to acute intestinal
199        MZ B cells rapidly differentiate into antibody-secreting cells in response to allotransplantat
200      Human B cells proliferate and turn into antibody-secreting cells in response to TLR3, TLR7 and T
201  i.n. immunization induced predominantly IgA antibody-secreting cells in salivary glands and IgA and
202 tibody levels and the number of HSV-specific antibody-secreting cells in secondary lymphoid tissues w
203 ollicles and differentiate into cytokine and antibody-secreting cells in T-independent and T-dependen
204                 We enumerated donor-specific antibody-secreting cells in the blood of nine renal allo
205 We sought to quantify B-cell populations and antibody-secreting cells in the blood of patients with A
206 n lymph nodes, lungs and spleen, and boosted antibody-secreting cells in the bone marrow.
207    BALB/b mice had 25-fold more MHV-specific antibody-secreting cells in the central nervous system,
208  monoclonal antibodies (hMAbs) directly from antibody-secreting cells in the circulation of immunized
209 antly enhanced the number of AgI/II-specific antibody-secreting cells in the draining superficial cer
210 LPS in lung lavages and specific IgG and IgA antibody-secreting cells in the lungs and spleen.
211 ollicular helper (GC Tfh) and GC B cells and antibody-secreting cells in the spleen and bone marrow i
212 igen-specific immunoglobulin G (IgG) and IgA antibody-secreting cells in the spleen and draining lymp
213 and compare the dynamics of antigen-specific antibody-secreting cells in the spleen and kidney of pri
214 ing cells in salivary glands and IgA and IgG antibody-secreting cells in the superficial and central
215 raoral immunization also induced IgA and IgG antibody-secreting cells in the superficial and central
216 d virus-specific antibodies in the serum and antibody-secreting cells in their secondary lymphoid org
217                             The frequency of antibody-secreting cells in tissues, postulated to funct
218 eting cells, including listeria-specific IgA antibody-secreting cells, in the lamina propria of the s
219 patients, and a 10-fold decrease in anti-DNA antibody-secreting cell lines was found after treatment
220 subcutaneous (neck) immunization induced IgG antibody-secreting cells mainly in the draining facial l
221 stribution and maintenance of these critical antibody-secreting cells may serve as potential therapeu
222 eutralizing antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and gamma inte
223 oth total and RV-specific murine IgM and IgA antibody-secreting cells migrate efficiently to CCL28 (t
224 ells become activated and differentiate into antibody-secreting cells more rapidly than naive B cells
225 y lower measles-specific antibody levels and antibody-secreting cell numbers were also observed, indi
226 quality of antibody and coupled with reduced antibody-secreting cell numbers.
227 1, 3, and 4 showed a significant increase in antibody-secreting cells on ELISPOT.
228 rise from B220(+) memory B cells and produce antibody-secreting cells on rechallenge with antigen.
229 serum antibody responses (p < 0.05) and more antibody-secreting cells (p < 0.05).
230 nge with an average of 3253 IgA and 1227 IgG antibody-secreting cells per million peripheral blood mo
231           NV-specific memory B cells but not antibody-secreting cells persisted 180 days after infect
232  early to immune challenge and display a pre-antibody-secreting cell phenotype.
233 using a live virus neutralization assay, and antibody-secreting cell population frequencies were dete
234 gD(neg)CD27(neg)CD11c(+)CXCR5(neg) (DN2) pre-antibody secreting cell (pre-ASC) subset.
235 ts suggest strategies to remove xenoreactive antibody-secreting cells prior to transplantation.
236                                              Antibody-secreting cells producing antilipopolysaccharid
237                               In these mice, antibody-secreting cells recognizing multivalent antigen
238 ti-BLyS treatment, yet the number of natural antibody-secreting cells remained constant.
239                    Most vaccinees had an IgA antibody-secreting cell response against colonization fa
240 ix volunteers that received 10(4) CFU had an antibody-secreting cell response, and four had a serum I
241 ived 10(3) CFU excreted SC602 and had an IgA antibody-secreting cell response.
242 ling in the development of anti-WNV-specific antibody-secreting cell responses and memory B cell resp
243    Although many of the volunteers generated antibody-secreting cell responses to Vi, only 2 of the 3
244                                              Antibody-secreting cell responses were biased toward IgA
245 compared to rLBNSE, could differentiate into antibody-secreting cells, resulting in rapid and potent
246 lipopolysaccharide responses, as measured by antibody-secreting cell, serum, or fecal antibody levels
247 nduced similar frequencies of stalk-reactive antibody-secreting cells, showing that HA head immunodom
248 differentiation, which cooperate to generate antibody-secreting cells that cause the deposition of an
249 ic IgM(+) MBCs proliferated and gave rise to antibody-secreting cells that dominated the early second
250                     The level of circulating antibody-secreting cells that make anti-galalpha1-3gal a
251 -cells to proliferate and differentiate into antibody-secreting cells that morphologically resemble p
252 en and induced B cells to differentiate into antibody-secreting cells that produced DSAs.
253 ant increase in the iliac lymph nodes of IgA antibody-secreting cells to p27 (P < 0.02), CD8-suppress
254  in these children differentiated quickly to antibody-secreting cells to the new vaccine antigens.
255             B lymphocytes differentiate into antibody-secreting cells under the antigen-specific cont
256 (anti-LGI1 mAb) derived from a patient's CSF antibody-secreting cell was infused intracerebroventricu
257 ver, in vitro differentiation of memBcs into antibody-secreting cells was 6.1-, 2.6-, and 3.7-fold si
258                    The number of Ag-specific antibody-secreting cells was transiently reduced, but th
259 are required for B-cell differentiation into antibody-secreting cells, we found that MM cells inheren
260                        In addition, specific antibody-secreting cells were detectable in the lamina p
261 oreover, robust circulating VP1-specific IgA antibody-secreting cells were detected 1 week postvaccin
262                                   Long-lived antibody-secreting cells were detected in the bone marro
263                           F protein-specific antibody-secreting cells were detected in the bone marro
264                                  Circulating antibody-secreting cells were enumerated using enzyme-li
265 tantial populations of endemic HCoV-reactive antibody-secreting cells were identified and possessed h
266  were detected in lung lavages, and specific antibody-secreting cells were isolated from the spleen a
267     Antibody production and the frequency of antibody-secreting cells were significantly elevated in
268  in a dramatic reduction of antigen-specific antibody-secreting cells, whereas deletion of relb had n
269 f-HA causes a population of immunoglobulin G antibody-secreting cells, which dominate the primary res
270 (T(FH)) cells are CD4(+) T cells that select antibody secreting cells with high antigenic affinity in
271 ly polarized antibody repertoire in CD138(+) antibody-secreting cells within the PLN.

 
Page Top